Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1671858 · SPRY

ARS Pharmaceuticals, Inc.

Filing with the SEC SEC-reporting company San Diego, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $171M for the year (2024: $8M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$84.3M$89.1M
Net income (loss)−$171M$8M
Total assets$328M$351M
Total liabilities$213M$94.4M
Stockholders’ equity$114M$257M
Cash and equivalents$41.3M$50.8M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
ARS Pharmaceuticals, Inc.
Formerly: Silverback Therapeutics, Inc.
CIK
0001671858
Tickers
SPRY
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
San Diego, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 5, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 5, 2026 · filing · edition of Nov 5, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 5, 2026 · filing · edition of Nov 5, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 17, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 7, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 15, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 15, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed May 13, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 9, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 9, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 10, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 10, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 14, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 20, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 20, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Jan 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 13, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 6, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 9, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 21, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 21, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 7, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 9, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 9, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Aug 31, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 10, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 10, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 15, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 15, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 23, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 23, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Feb 14, 2023 · filing